RS Sankhala, V Dussupt, WH Chen, H Bai, EJ Martinez… - Structure, 2024 - cell.com
Given the continuous emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VoCs), immunotherapeutics that target conserved …
D Guerra, L Radić, M Brinkkemper… - Human Vaccines & …, 2024 - Taylor & Francis
Monoclonal neutralizing antibodies (mAbs) are considered an important prophylactic against SARS-CoV-2 infection in at-risk populations and a strategy to counteract future …